Summary
CME Group Inc. held its 2023 Annual Meeting of Shareholders on May 4, 2023, where key governance matters were put to a vote. The meeting saw strong shareholder support for the re-election of seventeen Equity Directors and the ratification of Ernst & Young LLP as the independent auditor. However, a significant advisory vote against the compensation of named executive officers indicates shareholder concern on this front. Notably, the Company announced that the advisory vote on executive compensation was not approved, with a majority voting against it. The shareholders did, however, vote for annual advisory votes on executive compensation, a frequency that will be maintained until 2029. In a unique outcome, elections for several Class B Directors did not achieve quorum, leading to these directors continuing as "holdovers" under Delaware law until their successors are elected at the next annual meeting.
Key Highlights
- 1Shareholder turnout was robust, with 86.27% of Class A and B common stock represented at the Annual Meeting.
- 2All seventeen proposed Equity Directors were re-elected, demonstrating board continuity and shareholder confidence in the current leadership of these roles.
- 3Ernst & Young LLP was ratified as the independent public accounting firm for 2023 with strong shareholder approval.
- 4The advisory vote on the compensation of named executive officers was **not approved**, with a significant majority voting against it.
- 5Shareholders overwhelmingly approved holding an advisory vote on executive compensation annually, setting this frequency until 2029.
- 6Elections for Class B Directors in B-1, B-2, and B-3 categories did not achieve quorum, resulting in "holdover" directors who will continue their service until successors are elected.